Prelude Therapeutics, Inc. (PRLD)
5.34
-0.13
(-2.38%)
USD |
NASDAQ |
Aug 31, 09:54
Prelude Therapeutics Market Cap : 425.90M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 436.27M |
| August 27, 2026 | 505.66M |
| August 26, 2026 | 523.21M |
| August 25, 2026 | 525.60M |
| August 24, 2026 | 516.03M |
| August 21, 2026 | 528.79M |
| August 20, 2026 | 518.42M |
| August 19, 2026 | 461.00M |
| August 18, 2026 | 458.60M |
| August 17, 2026 | 449.03M |
| August 14, 2026 | 442.65M |
| August 13, 2026 | 427.50M |
| August 12, 2026 | 457.01M |
| August 11, 2026 | 424.31M |
| August 10, 2026 | 385.23M |
| August 07, 2026 | 390.81M |
| August 06, 2026 | 373.26M |
| August 05, 2026 | 286.10M |
| August 04, 2026 | 284.84M |
| August 03, 2026 | 276.65M |
| July 31, 2026 | 289.88M |
| July 30, 2026 | 318.24M |
| July 29, 2026 | 296.82M |
| July 28, 2026 | 292.40M |
| July 27, 2026 | 245.14M |
| Date | Value |
|---|---|
| July 24, 2026 | 241.36M |
| July 23, 2026 | 247.66M |
| July 22, 2026 | 247.35M |
| July 21, 2026 | 254.59M |
| July 20, 2026 | 255.85M |
| July 17, 2026 | 264.68M |
| July 16, 2026 | 263.42M |
| July 15, 2026 | 281.06M |
| July 14, 2026 | 276.65M |
| July 13, 2026 | 279.80M |
| July 10, 2026 | 302.80M |
| July 09, 2026 | 309.42M |
| July 08, 2026 | 322.65M |
| July 07, 2026 | 313.20M |
| July 06, 2026 | 314.46M |
| July 02, 2026 | 309.42M |
| July 01, 2026 | 309.42M |
| June 30, 2026 | 335.89M |
| June 29, 2026 | 310.68M |
| June 26, 2026 | 276.02M |
| June 25, 2026 | 258.37M |
| June 24, 2026 | 269.09M |
| June 23, 2026 | 276.02M |
| June 22, 2026 | 272.24M |
| June 18, 2026 | 272.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.759B |
| Twist Bioscience Corp. | 8.516B |
| Beam Therapeutics, Inc. | 2.953B |
| Revolution Medicines, Inc. | 43.62B |
| Sana Biotechnology, Inc. | 1.140B |
Market Cap Related Metrics
| PS Ratio | 19.05 |
| Price to Book Value | 3.185 |
| Price | 5.34 |
| Earnings Yield | -14.75% |